• Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors

  • 2021/02/11
  • 再生時間: 19 分
  • ポッドキャスト

Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors

  • サマリー

  • Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others.

    続きを読む 一部表示

あらすじ・解説

Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others.

Repurposing rheumatology drugs for COVID-19: Interleukin inhibitorsに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。